Advertisement
The event was presided over by Dr Ashwath Narayan CN, Minister of Higher Education, IT & BT, Govt of Karnataka, Dr. Thrilok Chandra, IAS, Special Health Commissioner, BBMP, Dr. Ramesh Hariharan, CEO & Co-Founder, Strand Life Sciences, Prof. Rajesh Sundaresan, IISc, Professor, Dr Vishal US Rao, Member of Genomic Surveillance Committee, Karnataka, and Director – Head and Neck Oncology, HCG Cancer Hospital, and Prof. Rakesh Mishra, Director, Tata Institute for Genetics and Society.
RTPCR +ve samples were collected between July 2021 and June 2022 from various laboratories in Bengaluru, Karnataka, with due permissions from BBMP. These samples were then sequenced and analyzed for variants and strains at Strand’s laboratories, and the findings were conveyed to the Karnataka State and BBMP public health officials in conjunction with INSACOG (Indian SARS-CoV-2 Genetics Consortium) labs like InStem, the key stakeholders for this project.
The project was supported primarily by philanthropic funding from IN Covid Support, supplemented with funding from organisations like ACT Covid Response Collective.
Related Articles
Advertisement
Dr Ashwath Narayan CN, Minister of Higher Education, IT & BT, Govt of Karnataka, said, “A vital component of managing public health is keeping up with virus mutations and lineages. We have taken active measures to encourage genomic sequencing to enable detection of new variants proactively. This effort by Strand Life Sciences has played a significant role in understanding the spread and identifying relevant solutions to control the spread of the virus.”